FDA Continues Weight-Loss Supplement Investigation
In a continuing investigation, FDA (Rockville, MD) has determined that dozens of weight-loss supplements, most of them imported from China, contain hidden and potentially harmful drugs. The agency plans to issue a longer list of brands to avoid that are spiked with drugs in the coming weeks, an FDA spokeswoman said.
In a continuing investigation, FDA (Rockville, MD) has determined that dozens of weight-loss supplements, most of them imported from China, contain hidden and potentially harmful drugs. The agency plans to issue a longer list of brands to avoid that are spiked with drugs in the coming weeks, an FDA spokeswoman said.
Late last year, FDA ruled that StarCaps, papaya-infused weight loss capsules promoted as natural dietary supplements, were potential health hazards. The capsules contained pharmaceutical drug, bumetanide.
So far, the FDA has cited 69 tainted weight-loss supplements.
An in-depth story can be found here: http://www.nytimes.com/2009/02/10/business/10pills.html?_r=1&hp
The impact of GLP-1 on supplements, functional foods, and retail: a webinar from CRN
January 29th 2025The recent CRN webinar discussed GLP-1 medications' impact on supplements, functional foods, and retail, covering consumer trends, global market insights, retailer strategies, industry implications, and future opportunities for innovation.
